BioNTech SE (BNTX)

BioNTech SE Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-1,136	-665.3	930.3	9,434	10,293
Depreciation & Amortization	185.3	156.6	183.4	123.3	75.2
Loss (Gain) From Sale of Assets	-2.5	-0.3	3.8	0.6	4.6
Asset Writedown & Restructuring Costs	197.5	141.4	-	-	-
Loss (Gain) From Sale of Investments	-10.4	4.6	175.5	-241	57.3
Stock-Based Compensation	80.9	-53.6	-714.8	56.8	80.5
Other Operating Activities	603.5	-596.3	-781.6	-315.2	1,110
Change in Accounts Receivable	1,084	387.7	5,374	4,370	-11,808
Change in Inventory	177.9	74.5	81.9	62.9	-438.4
Change in Accounts Payable	-723.8	758.4	118.9	85.7	1,516
Operating Cash Flow	456	207.7	5,371	13,577	889.7
Operating Cash Flow Growth	119.55%	-96.13%	-60.44%	1426.07%	-
Capital Expenditures	-175.1	-286.5	-250.1	-329.2	-127.5
Sale of Property, Plant & Equipment	4.5	1.2	-	0.6	3.4
Cash Acquisitions	186.3	-	-336.9	-	-20.8
Sale (Purchase) of Intangibles	-573.9	-165.8	-455.4	-34.1	-26.5
Investment in Securities	-1,910	-1,630	-5,912	327.4	-394.7
Investing Cash Flow	-2,469	-2,081	-6,955	-35.3	-566.1
Long-Term Debt Issued	6.7	-	0.3	0.8	-
Long-Term Debt Repaid	-57.6	-45.9	-40.4	-59.9	-66.7
Net Debt Issued (Repaid)	-50.9	-45.9	-40.1	-59.1	-66.7
Issuance of Common Stock	-	-	-	110.5	163.6
Repurchase of Common Stock	-	-	-738.5	-986.4	-
Other Financing Activities	-2	-	-	-	-2.7
Financing Cash Flow	-52.9	-45.9	-778.6	-1,419	94.2
Foreign Exchange Rate Adjustments	-27	14.8	-14.5	60.1	64.7
Miscellaneous Cash Flow Adjustments	5.9	2.8	164.8	-0.5	-
Net Cash Flow	-2,087	-1,902	-2,211	12,182	482.5
Free Cash Flow	280.9	-78.8	5,121	13,248	762.2
Free Cash Flow Growth	-	-	-61.34%	1638.15%	-
Free Cash Flow Margin	9.79%	-2.86%	134.10%	76.53%	4.02%
Free Cash Flow Per Share	1.16	-0.33	21.10	53.03	2.94
Cash Interest Paid	11	13.5	5.4	21.5	12.2
Cash Income Tax Paid	-3.8	389.2	482.9	4,222	3,458
Levered Free Cash Flow	-1,098	-548.4	4,139	12,009	-646.6
Unlevered Free Cash Flow	-1,089	-537.84	4,144	12,020	-629.54
Change in Working Capital	537.8	1,221	5,575	4,519	-10,730

Updated Mar 10, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q